332 related articles for article (PubMed ID: 33444690)
1. Metabolic adaptation in hypoxia and cancer.
Paredes F; Williams HC; San Martin A
Cancer Lett; 2021 Apr; 502():133-142. PubMed ID: 33444690
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1α in cancer.
Hayashi Y; Yokota A; Harada H; Huang G
Cancer Sci; 2019 May; 110(5):1510-1517. PubMed ID: 30844107
[TBL] [Abstract][Full Text] [Related]
3. Oxygen-sensing in tumors.
Verma A
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):366-78. PubMed ID: 16778564
[TBL] [Abstract][Full Text] [Related]
4. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells and hypoxia-inducible factors (Review).
Tong WW; Tong GH; Liu Y
Int J Oncol; 2018 Aug; 53(2):469-476. PubMed ID: 29845228
[TBL] [Abstract][Full Text] [Related]
6. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
8. Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.
Kappler M; Pabst U; Weinholdt C; Taubert H; Rot S; Kaune T; Kotrba J; Porsch M; Güttler A; Bache M; Krohn K; Bull F; Riemann A; Wickenhauser C; Seliger B; Schubert J; Al-Nawas B; Thews O; Grosse I; Vordermark D; Eckert AW
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554283
[TBL] [Abstract][Full Text] [Related]
9. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.
Kim JY; Lee JY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841148
[TBL] [Abstract][Full Text] [Related]
10. USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression.
Tu R; Kang W; Yang M; Wang L; Bao Q; Chen Z; Dong Y; Wang J; Jiang J; Liu H; Qing G
Oncogene; 2021 Nov; 40(46):6417-6429. PubMed ID: 34601505
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
[TBL] [Abstract][Full Text] [Related]
14. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis.
Nagaraju GP; Bramhachari PV; Raghu G; El-Rayes BF
Cancer Lett; 2015 Sep; 366(1):11-8. PubMed ID: 26116902
[TBL] [Abstract][Full Text] [Related]
16. Metabolic priming by multiple enzyme systems supports glycolysis, HIF1α stabilisation, and human cancer cell survival in early hypoxia.
Grimm F; Asuaje A; Jain A; Silva Dos Santos M; Kleinjung J; Nunes PM; Gehrig S; Fets L; Darici S; MacRae JI; Anastasiou D
EMBO J; 2024 Apr; 43(8):1545-1569. PubMed ID: 38485816
[TBL] [Abstract][Full Text] [Related]
17. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia.
Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A
Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells.
Chiu DK; Zhang MS; Tse AP; Wong CC
Methods Mol Biol; 2019; 1928():77-99. PubMed ID: 30725452
[TBL] [Abstract][Full Text] [Related]
19. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
[TBL] [Abstract][Full Text] [Related]
20. Expression and stability of hypoxia inducible factor 1α in osteosarcoma.
El Naggar A; Clarkson P; Zhang F; Mathers J; Tognon C; Sorensen PH
Pediatr Blood Cancer; 2012 Dec; 59(7):1215-22. PubMed ID: 22544557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
